FFTY Innovator IBD® 50 ETF

USD 25.38 -0.16 -0.607129
Icon

Innovator IBD® 50 ETF (FFTY) Stock Analysis and Price Targets

ETF | Mid-Cap Growth | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 25.38

-0.16 (-0.61)%

USD 0.09B

0.05M

N/A

N/A

Icon

FFTY

Innovator IBD® 50 ETF (USD)
ETF | NYE
USD 25.38
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.09B

N/A

USD 25.38

Innovator IBD® 50 ETF (FFTY) Stock Forecast

N/A

Based on the Innovator IBD® 50 ETF stock forecast from 0 analysts, the average analyst target price for Innovator IBD® 50 ETF is not available over the next 12 months. Innovator IBD® 50 ETF’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Innovator IBD® 50 ETF is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Innovator IBD® 50 ETF’s stock price was USD 25.38. Innovator IBD® 50 ETF’s stock price has changed by -6.23% over the past week, -6.57% over the past month and +4.30% over the last year.

No recent analyst target price found for Innovator IBD® 50 ETF
No recent average analyst rating found for Innovator IBD® 50 ETF

Company Overview Innovator IBD® 50 ETF

The fund will normally invest at least 80% of its net assets (including investment borrowings) in securities that comprise the index. The IBD® 50 Index is a weekly, rules-based, computer-generated stock index compiled and published by Investor's Business Daily® (IBD or the inde...Read More

http://innovatoretfs.com/

N/A

N/A

N/A

USD

USA

08/04/2015

IBD 50 Index USD

S&P 500 TR USD

0.80 %

Adjusted Closing Price for Innovator IBD® 50 ETF (FFTY)

Loading...

Unadjusted Closing Price for Innovator IBD® 50 ETF (FFTY)

Loading...

Share Trading Volume for Innovator IBD® 50 ETF Shares

Loading...

Compare Performance of Innovator IBD® 50 ETF Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for FFTY

Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

  • 1

  • S&P 500 TR USD

  • 3

  • 27.01

  • 0.00

  • -0.50

  • 4.12%

  • -16.98%

  • -4.98%

  • 0%

Stocks Similar To Innovator IBD® 50 ETF (Sector: Mid-Cap Growth )

Symbol Name Mer Price(Change) Market Cap
VOT
Vanguard Mid-Cap Growth Index .. 0.07 % -1.08 (-0.49%) USD24.16B

ETFs Containing FFTY

Symbol Name FFTY's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Innovator IBD® 50 ETF (FFTY) Stock

Stock Target Advisor's fundamental analysis for Innovator IBD® 50 ETF's stock is Very Bearish.

FFTY stock's dividend yield is 0.57%. Our analysis grades FFTY stock's dividend yield at F. This means that FFTY stock's dividend yield is above 27% of the stocks in the Mid-Cap Growth sector in the NYE exchange. Based on this FFTY may be a poor dividend stock for its sector.

Unfortunately we do not have enough data on FFTY's stock to indicate what its average analyst target is.

FFTY stock's Price/Earning ratio is 29.80. Our analysis grades FFTY stock's Price / Earning ratio at F. This means that FFTY stock's Price/Earning ratio is above 94% of the stocks in the Mid-Cap Growth sector in the NYE exchange. Based on this FFTY may be a overvalued for its sector.

The last closing price of FFTY's stock was USD 25.38.

The most recent market capitalization for FFTY is USD 0.09B.

Unfortunately we do not have enough analyst data on FFTY's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Innovator IBD® 50 ETF's stock.

Sorry, we do not have any data on the number of employees for Innovator IBD® 50 ETF.

Sorry we do not have any infomation available on Innovator IBD® 50 ETF's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...